Long‐term safety of perampanel and seizure outcomes in refractory partial‐onset seizures and secondarily generalized seizures: Results from phase III extension study 307

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|55|7|1058-1068

ISSN： 0013-9580

Source： EPILEPSIA, Vol.55, Iss.7, 2014-07, pp. : 1058-1068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America

By  

EPILEPSIA, Vol. 56, Iss. 4, 2015-04 ,pp. : 546-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1077-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures

By  

EPILEPSIA, Vol. 56, Iss. 7, 2015-07 ,pp. : e90-e94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

By  

EPILEPSIA, Vol. 56, Iss. 2, 2015-02 ,pp. : 244-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lacosamide for the treatment of partial-onset seizures

By Wong Matthew H   Fountain Nathan B  

Therapy, Vol. 7, Iss. 5, 2010-09 ,pp. : 459-465

Future Medicine

Access to resources Recommend Favorite